The Power of Market Research in Increasing Damages in Patent Infringement
Securing a ruling in your favor in an infringement case is a win, but translating that into a fair financial recovery is the real challenge. This scenario is all too common. You’ve built a winning claim chart and proven infringement, yet the proposed damages for patent infringement fall far short of reflecting the true value […]
The Only Tool You Need To Determine Potential Standard Essential Patents
Technical standards, evolving technologies, and scattered patent declarations complicate the process of determining standard essential patents (SEPs). This is further complicated by the need for manual searches across various databases, which are time-consuming and prone to errors and omissions. However, what if there was a solution that could simplify this process? GreyB’s 3GPP tool addresses […]
Going beyond online literature to verify the true patent infringement potential
Online resources such as product manuals and company websites are a good starting point for patent infringement analysis. However, these sources can often be inconclusive, making it difficult to determine if a target company is actually infringing on a particular patent. A similar challenge arose when a client approached our team with a specific request […]
The Ofev Patent Thicket: Patents expiring in 2026
With an average life expectancy of 3-5 years after diagnosis, Pulmonary fibrosis highlights an urgent need for innovative therapeutic interventions. That’s where medications like Ofev have emerged as a transformative solution. Ofev is the trade name for Nintedanib by Boehringer Ingelheim. It is a Tyrosine Kinase Inhibitor (TKI) or anti-fibrotic agent used to treat non-small […]
Newracom’s Wi-Fi 6 Patent Portfolio: A Dive Into Unacquired Assets & Their Potential
While early identification of Wi-Fi 7 SEPs is the long-term vision, immediate dominance in the wireless domain comes from identifying the sellers of Wi-fi 6 patents with enforceable portfolios. Wi-Fi 6 is an evolving market, and while innovating and filing patents once dominated, things have changed. With the emergence of Wi-Fi 7 and its ongoing […]
Build a Strong Wi-Fi 7 Patent Portfolio Before Market Entry
Major players like ZTE, Xiaomi, Zyxel, Sagemcom, Maxlinear, TP-Link, Buffalo, Gemtek, and a few others have already begun marketing their Wi-Fi 7 routers, following the certifications received from the Wi-Fi Alliance. The early days of Wi-Fi 6 were marked by a similar rush to market. However, Wi-Fi manufacturers such as D-Link, Sercom, and Acer (having […]
4 AI Tools For Every IP Professional to Swifty Understand the Patents
Like every other industry, Artificial Intelligence (AI) has also transformed intellectual property (IP). With reduced human effort, patent experts can refine how they read, analyze, and leverage IP. Unsurprisingly, multiple AI tools that make patents easier to understand have entered the market. This article presents the top 4 AI Tools for quick and easy understanding […]
The Trajenta Patent Thicket: Patents expiring in 2025
Trajenta, known for its effective glycemic control without weight gain, is a key player in the diabetes medication sector. This critical medication, known generically as Linagliptin, is on the brink of its patent expiration, presenting an opportunity for generic drug manufacturers to introduce their own generic versions. Manufactured by Boehringer Ingelheim, Trajenta® is an oral […]
Qi Standard Mapping: Smart IP Licensing Move to Boost Revenue
IP Licensing is no longer a unique practice in dynamic technology domains. However, the key to success lies in finding the smartest and most creative strategy for analyzing infringement, which can significantly increase the revenue generated from a single patent. But what exactly will be the smartest strategy? This case study exemplifies how QI standard mapping […]
Strategic Considerations After The New “Skilled Searcher” Standard For IPR Estoppel
Ironburg Inventions, known for its SCUF controllers, claimed that Valve’s Steam Controller infringed on its patents. Specifically, the patents in question were related to the back paddle design of controllers, a feature that SCUF Gaming has heavily marketed and patented. However, it isn’t these details of the case that make it worth mentioning but the […]
Quickly Identify Non-SEPs To Optimize Your SEP Licensing Strategy
Identifying Standard Essential Patents (SEPs) is a resource-intensive task, especially when dealing with a large patent portfolio. In this process, manual analysis is the preferred method, but examining patents that are unlikely to be SEPs can lead to inefficient portfolio management and limit strategic decision-making during SEP licensing. Therefore, to avoid investing valuable resources into […]
Recent Patent Oppositions in the Pharmaceutical Industry
The European Patent Office (EPO) receives more than 2000 oppositions each year, directly impacting the future success and exclusivity of pharmaceutical products. Monitoring the outcomes of these oppositions is crucial as it assists in developing effective strategies for launching generic versions of drugs. Moreover, it aids in identifying competitors that may be eating into market […]
Understanding the Farxiga®/Forxiga® Patent Thicket: What’s Changing in 2025
While numerous drugs for diabetes are available in the market, many come with undesirable side effects such as weight gain, hypoglycemia, and hypertension. However, a game-changing solution has been introduced in the form of Farxiga®/Forxiga®. Farxiga®/Forxiga® is the trade name for Dapagliflozin, by AstraZeneca. It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, representing a novel […]
73 Drugs Losing Europe Exclusivity in 2024
In Europe, 2024 marks the year when exclusivity for a diverse range of drugs encompassing various therapeutic categories is set to expire. This includes established medications like Cabometyx and Zavicefta and breakthrough treatments like Tagrisso. The article provides a list of 73 such drug patents across diverse therapeutic categories, ranging from antivirals to antineoplastics, reflecting […]
Dolby’s Strategy to Double Versatile Video Coding Standard Patent Licensing Returns
Streaming crystal-clear 8K content on a phone without buffering, even on unreliable internet, is no longer a far-fetched thought. This seemingly magical experience relies heavily on the intricate video compression technologies developed by industry leaders like Dolby and JVC Kenwood. Although this is commonly known, these companies are being highlighted in this case study for […]
8 Months In, the Unitary Patent & Court: Unmasking Industry Reactions & Shaping Your Next Move
In the eight months since its introduction, the Unitary Patent System has initiated a significant transformation in the field of patent law within the European Union. This article aims to offer an insightful overview of the Unitary Patent and Unified Patent Court, shedding light on how this system benefits various sectors, the notable cases that […]
